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Abstract 
Background: The selective proliferation of transplanted hepatocytes by providing a 
growth stimulus, such as partial hepatectomy or hepatocyte growth factor, 
concomitant with hepatic irradiation (HIR) that can suppress proliferation of host 
hepatocytes was reported.  We have conducted experiments which focus on I) less 
invasive and clinically applicable techniques and II) progenitor cells.  Materials 
and methods: I) Dipeptidyl-peptidase IV (DPPIV)−F344 or jaundiced Gunn rats 
received partial HIR (only 30% of whole liver) and portal vein branch ligation 
(PVBL) of one lobe, followed by intrasplenic hepatocyte transplantation at 1x107.  
II) After partial HIR+PVBL, two kinds of progenitor cells were transplanted, i.e., 
small hepatocytes (SHs) or adipose derived mesenchymal stem cells (ADMSCs).  
Results: I) Sixteen weeks later, the donor cells constituted more than 70% of the 
hepatocytes of the irradiated lobe, showing connexin 32, PCK-1 and glycogen 
storage.  Moreover, the serum bilirubin level decreased significantly in jaundiced 
Gunn rats and remained at this level throughout the 24-week experimental period.  
II): SHs grew more quickly than hepatocytes, and after 8 weeks, around 40% of 
host hepatocytes were replaced with transplanted SHs.  2) Although donor cells 
were engrafted after 8 weeks, their proliferation was not observed.  Conclusion: 
HIR can be given to a selective lobe of liver and is a low-invasive and effective 
means for transplanted hepatocytes to proliferate combined with PVBL.  Even a 
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smaller number of SHs can construct liver tissue with their prevailing 
proliferative ability. 
Key words; hepatocyte transplantation, hepatic irradiation, portal vein branch 
ligation, small hepatocyte, adipose derived mesenchymal stem cell 




Hepatocyte transplantation (HT) has been performed in both animal experiments 
and in patients with hepatic inherited disorders (1-4).  Because the number of 
hepatocytes transplanted safely at one time is limited due to the occurrence of 
portal hypertension, transplanted hepatocytes need to proliferate in the host liver 
to completely correct the underlying disorder (5, 6).  Selective proliferation of 
transplanted hepatocytes by providing a growth stimulus by partial hepatectomy 
of the host liver, combined with hepatic irradiation (HIR) of the whole liver that 
can suppress proliferation of host hepatocytes, and consequently, almost the whole 
liver would be constructed with donor hepatocytes (7).  Moreover, jaundiced Gunn 
rats of Crigler-Najjar syndrome type I model, which lack hepatic 
uridinediphosphoglucuronate glucuronosyltransferase (UGT1A1) activity, had 
UGT1A1 protein and enzymatic activity in the liver, and normalization of serum 
bilirubin levels (8).  Although these results are very attractive, hepatectomy is too 
invasive to be carried out in patients.  Instead of hepatectomy, Fas-mediated 
apoptosis of host hepatocytes (9) or administration of a recombinant adenovirus 
vector expressing hepatocyte growth factor (HGF) (10, 11) has been successful in 
inducing massive repopulation of transplanted hepatocytes.  However, these 
strategies appear difficult to implement clinically because of potential toxicity.   
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Irradiation-induced apoptosis of hepatocytes and sinusoidal endothelial cells 
within 24 hours after HIR improved by one week (12).  Chronically, 
radiation-induced liver disease (RILD), characterized by histopathologic features 
of veno-occlusive disease, could occur within several months after hepatic 
radiation therapy, and the patient, with irradiation of an extended liver volume, 
would show fatigue, weight gain, hepatomegaly, and ascites (13).  Recently, Zhou 
et al. reported single liver lobe repopulation with transplanted hepatocytes cured 
jaundice in Gunn rats using preparative regional HIR, in order to reduce the 
susceptibility to RILD (14).  They injected an adenovirus vector expressing HGF 
to provide a proliferative stimulus.  Previously, as potential clinically applicable 
methods, Eguchi et al. demonstrated that regenerative stimulus by portal vein 
branch ligation (PVBL) induced proliferation of transplanted hepatocytes and 
enhanced the therapeutic efficacy of HT in hyperlipidemic rabbits (15).  In clinical 
settings, a portal vein occlusion can be made by embolization with radiological 
intervention. This is often used as a preparation to elicit liver hypertrophy in the 
nonembolized lobes with liver atrophy in the embolized lobes in the patient who 
has a scheduled extended hepatectomy (16).  We addressed the partial HIR of 
single lobe combined with PVBL, as preparation for the induction of selective 
proliferation of transplanted hepatocytes. 
Another essential obstacle to clinical HT is the shortage of donor hepatocytes.  In 
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the present study, we investigated the utility of small hepatocytes (SHs), which are 
known as progenitor cells of hepatocytes in the liver, and have a significant ability 
to proliferate both in vitro (17) and in vivo (18) in rat.  In addition, we tried stem 
cell transplantation derived from adipose tissue.  Adipose derived mesenchymal 
stem cells (ADMSCs) have advantages in terms of minimal ethical issues and easy 
accessibility compared with other kinds of stem cells, such as bone 
marrow-derived or ES cells.   
 
Materials and Methods 
Animals 
Male wild-type F344 rats and dipeptidyl peptidase (DPP) IV deficient (DPPI−) 
F344 rats weighing 200-250 g were obtained commercially (Japan SLC, Inc., 
Hamamatsu, Japan and Charles River Laboratories Japan, Inc., Yokohama, 
Japan, respectively).  Both jaundiced Gunn/Slc-j/j and Gunn/Slc-j/ − 
(non-jaundiced) were purchased from Japan SLC, Inc.  The animals were housed 
in a temperature-controlled environment with a 12-hr light/dark cycle and had 
free access to standard rat chow and water.  All experiments were performed 
according to the Guidelines for Animal Experimentation at Nagasaki University. 
 
I) Experiment to assess the efficacy of preparative partial HIR+PVBL 
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Isolation of hepatocytes 
The cells were isolated with a modified collagenase perfusion method using male 
wild-type F344 rats or non-jaundiced Gunn/Slc-j/−rats, as originally described by 
Berry and Friend (19).  After liver dissociation, the cells were filtered through a 
70-μm Cell Strainer (Becton, Dickinson and Company, NJ, USA) and washed 
twice at 50×g for 2 min each.  Cell viability was determined by trypan blue dye 
exclusion.  Hepatocytes above 80% viability were used for transplantation. 
 
Partial hepatic irradiation and portal vein branch ligation 
Anesthesia was induced by ether inhalation and was maintained by the 
intraperitoneal injection of pentobarbital sodium with recipient animals (DPPIV−
F344 or jaundiced Gunn/Slc-j/j rats) and a transverse abdominal incision was 
made.  For partial hepatic irradiation (HIR) to only the left lateral lobe at 50 Gy, 
lead shields (2 mm thick) were placed to protect the other hepatic lobes and other 
abdominal organs.  A X-ray irradiation device (ISOVOLT TITAN 320; GE 
Inspection Technologies Ltd., Tokyo, Japan) was used (320 kVP, 5 mA, and 0.5 mm 
Cu + 0.5 mm Al filtration at dose rate 0.87 Gy/min).  Immediately after partial 
HIR, the portal vein supplying 20% of the liver was ligated to induce growth 
stimulus (Fig. 1).  Thereafter, the abdomen was closed. 




One to 3 days after the preparation, fresh hepatocytes were injected 
intrasplenically.  Hepatocytes at 1×107 from wild-type F344 rats or non-jaundiced 
Gunn/Slc-j/— rats were injected in either the anesthetized recipient DPPIV−F344 
rats or the jaundiced Gunn rats, respectively.   
 
Experimental design 
DPPIV rat experiment 
Six rats underwent HT after partial HIR+PVBL.  Two rats were killed at 4 and 
16 weeks after HT, respectively, and samples were collected for DPPIV 
histochemistry, PAS stain, and immunohistochemistry. 
Gunn rat experiment 
The rats were divided into three groups according to preparations (six for the 
non-HT group; only HIR+PVBL without HT, six for the PVBL group; HT following 
only PVBL, and eight for HIR+PVBL group; HT following HIR+PVBL).  Serum 
was collected from all the rats weekly until 24 weeks after HT to measure the 
serum bilirubin levels. 
 
Identification of transplanted cells by DPPIV histochemistry 
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DPPIV enzyme activity was detected as previously described (12).  Briefly, 5-μm 
thick cryostat sections of the liver were fixed in chloroform and acetone for 10 min 
at 4°C.  The sections were incubated for 30 min at 37°C in a solution 
containing 0.4 mg/ml glycyl-L-proline-4-methoxy-2-naphthylamide and 1 mg/ml 
Fast Blue B salt in TMS buffer (pH 6.5).  The proportion of repopulated areas by 
DPPIV positive donor cells to the total hepatic areas in each section was 
determined using the Photoshop CS5 software program (Adobe Systems Inc., CA, 
USA).   
 
Serum bilirubin concentrations 
The serum bilirubin concentrations were determined by enzymatic methods at 
SRL, Inc. (Tokyo, Japan). 
 
Detection of glycogen storage by PAS stain 
Tissue glycogen was determined by incubation in 1% aqueous periodic acid for 5 
min and Schiff’s reagent for another 15 min with cryostat sections fixed with cold 
methanol (20). 
 
Structural and functional investigation by immunohistochemistry 
To investigate whether repopulated donor hepatocytes had liver-specific structure 
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and function, cryostat sections fixed with cold acetone were stained using the 
mouse monoclonal anti-connexin 32 antibody (Abcam plc., Cambridge, UK) and 
the rabbit polyclonal anti-PCK-1 antibody (Abcam plc).  The antibody binding 
was then visualized using an EnVision/HRP (DAKO Japan corp., Tokyo, Japan). 
 
Proliferation cell nuclear antigen staining 
Proliferation cell nuclear antigen (PCNA) staining was performed to detect DNA 
synthesis as a marker of hepatocellular mitosis in response to the preparative 
treatments.  Other four DPPIV−F344 rats underwent HIR+PVBL, and 2 rats 
were killed on days 1 and 2 after the procedures, respectively.  
Immunohistochemical staining was performed using the mouse monoclonal 
anti-PCNA antibody (DAKO Japan corp.) and an EnVision/HRP with 
formalin-fixed paraffin-embedded sections.  
 
Serum hepatocyte growth factor levels after HIR+PVBL 
To investigate the changes in serum hepatocyte growth factor (HGF) levels, we 
performed HIR+PVBL without HT in the additional five DPPIV−F344 rats  
Serum specimens were collected 1, 3, 7, 14, 21, and 28 days after surgery.  The 
serum levels of HGF were measured using a Quantikine ELISA Mouse/Rat HGF 
Immunoassay kit (R&D Systems, Inc., MN, USA). 
Miyazaki, Yamanouchi, et al. 
 12 
 
II) Experiments for progenitor cell transplantation 
 
Fractions of parenchymal hepatocytes and small hepatocytes  
Fractions of parenchymal hepatocytes (PHs) and SHs from wild-type F344 rat 
liver were obtained as reported by Katayama et al. (18) with some modifications.  
The pellet obtained by collagenase perfusion and centrifugation at 50×g was 
additionally centrifuged through 45% Percoll at 50×g for 24 min.  The pellet thus 
obtained was further centrifuged at 50×g for 1 min, and the pellet and 
supernatant were used as a fraction of PHs and SHs, respectively. 
 
Isolation of ADMSCs 
ADMSCs were isolated from rat peritoneal adipose tissue specimens obtained 
from wild-type F344 rats as reported previously with some modifications (21).  
The tissue was rinsed with cold PBS (Life Technologies Japan Co., Tokyo, Japan.) 
and minced into small fragments with a blade.  The fragments were digested 
with 0.1 % collagenase type I (Life Technologies Japan Co.) in PBS for 60 min at 
37°C with vigorous shaking.  The top lipid layer was removed and the 
remaining digest was filtered through a 70-μm Cell Strainer and centrifuged at 
220×g for 10 min.  The pellet was treated with 160 mM NH4Cl for 10 min to lyse 
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the red blood cells.  The remaining cells were suspended in Dulbecco’s modified 
Eagle’s medium (Life Technologies Japan Co.) supplemented with 10% fetal bovine 
serum (Life Technologies Japan Co.) and plated at a density of 1×106 cells in a 
10-cm dish.  The culture media were changed thrice weekly.  The cells were 
maintained at subconfluent levels and passaged using trypsin/EDTA (Life 
Technologies Japan Co.). 
 
Experimental design 
Following HIR+PVBL, SHs or PHs (2×106), or ADMSCs of P2 to P4 (5×106)  were 
transplanted to four DPPIV−F344 rats, respectively.  They were then sacrificed 8 
weeks after HT for DPPIV histochemistry. 
 
Statistical analysis 
The results are expressed as the mean ± standard deviation (SD).  
Mann-Whitney’s U test was used for the comparison of 2 groups.  Data were 
analyzed using the analysis of variance (ANOVA) for multiple comparisons.  A 
p-value of less than 0.05 was considered to be statistically significant. 
 
Results 
Repopulation of transplanted hepatocytes in the irradiated lobes 
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After HT following preparative partial HIR+PVBL, transplanted hepatocytes 
grew and, subsequently, showed massive repopulation only in the irradiated lobes 
after 16 weeks, but did not display a similar behavior in the non-irradiated lobes 
(Fig. 2A).  In addition, immunohistochemical and PAS stains demonstrated 
expression of connexin 32, PCK-1, and glycogen storage in the repopulated 
hepatocytes, similar to the native liver (Figure. 2B, C, and D). 
 
Changes in the serum bilirubin concentrations 
Although the rats in the PVBL group showed significant, but transient decrease in 
serum bilirubin concentrations at 4 weeks after transplantation, the level 
recovered to preoperative value at 7 weeks and remained constant during the 
observation period (24 weeks).  In the HIR+PVBL group rats, serum bilirubin 
levels were reduced by 59.1% at 4 weeks after transplantation and kept this level 
for the remaining period of the observation (Fig. 3).  The animals in the non-HT 
group did not show any significant changes in their bilirubin levels.  
 
Regenerative response after partial HIR+PVBL 
DNA synthesis in proliferative hepatocytes was examined using PCNA staining.  
While in the non-irradiated liver lobe, many cells were PCNA-positive at 2 days 
after HIR+PVBL; in contrast, very few hepatocytes were PCNA-positive in the 
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irradiated lobe (Fig. 4).  To investigate the relevance of serum HGF with 
repopulation of transplanted hepatocytes, we measured its concentrations over 
time after HIR+PVBL by ELISA.  Unexpectedly, the serum HGF levels did not 
increase for at least 4 weeks (Fig. 5). 
 
Engraftment and repopulation of SHs and ADMSCs 
After 8 weeks of transplantation, a massive hepatic repopulation was acquired in 
the irradiated lobes with SHs, even with a small number of cells being 
transplanted initially (Fig. 6A).  The transplanted SHs proliferated more rapidly 
in the irradiated recipient’s liver compared with the PHs (38.5% vs. 7.2%, p<0.038) 
(Fig. 6E).  In addition, the repopulated SHs showed storage of glycogen (Fig. 6B).  
Although ADMSCs seemed to be engrafted in the recipient’s liver, no massive 
proliferation was obtained (Fig. 6C, D). 
 
Discussion 
 HT has been studied as an alternative method to liver transplantation in 
both the laboratory and clinical setting.  However, it has not been prevalent as a 
standard therapeutic option, mainly because of the limited number of hepatocytes 
at one time and the shortage of transplantable primary hepatocytes (4, 22).  To 
overcome these hurdles, the methods for growth of transplanted hepatocytes in 
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the recipient, or the development or availability of substitute for primary 
hepatocytes, such as xenogeneic hepatocytes, fetal hepatocytes, and hepatic stem 
cells/progenitor cells have been explored.   
The transplanted hepatocytes must grow over host hepatocytes to achieve 
repopulation in the host liver.  Portal vein embolization (PVE) is often used in the 
patient with a scheduled extended hepatectomy, as a preoperative intervention to 
elicit liver hypertrophy in the nonembolized lobes (16).  PVE is not accompanied 
by a lack of major tissue loss and we expected that this intervention would be a 
less invasive substitution for a partial hepatectomy to induce cell repopulation.  
In this study, we ligated a branch of the portal vein, supplying only one lobe, 
instead of PVE, because the animals were too small to carry out embolization.  
We performed partial HIR for 30% of the whole liver in order to induce minimal 
hepatic injury due to irradiation.  As a result, a massive repopulation was 
obtained only in the irradiated nonligated lobe, but the therapeutic effect was 
significant, as shown by a reduction in the serum bilirubin levels.  The serum 
bilirubin has been reported to decrease due to auxiliary partial liver 
transplantation with 12% of the liver in Gunn rat (23), thus suggesting that HIR 
in even smaller regions of the liver could be sufficient in our model.  Preparative 
PVBL alone, as a control, led to just a transient reduction in bilirubin.  There 
have been some reports in which therapeutic effect by HT with preparative HIR 
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alone was transient and minimum (8, 9).  PVBL could provide a selective growth 
stimulus to transplanted hepatocytes in combination with HIR, resulted in 
massive proliferation, and significant and continuous therapeutic effects.  
Furthermore, the hepatocytes proliferated while retaining normal structure and 
function, as demonstrated by positive staining of connexin32, PCK-1, and 
glycogen. 
 PCNA staining showed that PVBL induced a regenerative stimulus to 
hepatocytes.  We measured the levels of serum HGF, which is known as a strong 
stimulator for hepatocytes growth.  Although supplying HGF via an adenovirus 
vector was demonstrated to induce proliferation of transplanted hepatocytes (10, 
11, 14), PVBL did not increase the levels of HGF, as observed in the clinical PVE 
study (16).  Liver regeneration is regulated by an orchestrated and complex 
response, involving not only HGF, but also various kinds of mediators. Further 
studies are needed to clarify the mechanism of proliferation. 
 Because of a shortage of transplantable primary hepatocytes, we 
analyzed the ability in engraftment and proliferation of substitutive cells with the 
partial HIR+PVBL model.  SHs are known as progenitor cells in normal liver.  
As we expected, SHs proliferated in shorter periods than PHs did, due to the 
hepatic function of glycogen storage.  Although, in the present study, we did not 
assess either the characteristics of repopulated SHs or the therapeutic effects of 
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SH transplantation, Shibata and Hirata et al. demonstrated the therapeutic effect 
of transplantation with preparative partial hepatectomy + HIR in analbuminemic 
rats, comparable to mature hepatocytes (24).  SHs are in the non-parenchymal 
fraction in the liver (17, 18, 24).  In most clinical cases, hepatocytes for 
transplantation must be isolated from cadaver livers that were judged unsuitable 
for liver transplantation, i.e., macrosteatosis due to nonviral cirrhosis.  These 
livers often have critical problems in the isolation of hepatocytes, such as 
susceptibility to damage caused by ischemia, which is the major reason for poor 
viability of cells and which prevents high quality of hepatocytes from being 
obtained (25).  SHs might be useful for additional sources of cells as well as for the 
alteration of PHs, especially in the marginal livers. 
ADMSCs have been demonstrated to differentiate into various types of cells in 
vitro, including cells with hepatocyte-like forms and functions by adding some 
humoral factors (26).  We transplanted undifferentiated ADMSCs from peritoneal 
adipose tissue after HIR+PVBL, and did not obtain repopulation, though some 
cells were engrafted.  In the reported study, hepatocyte-like cells differentiated 
from ADMSCs in vitro, proliferated in the recipient liver with preparation of 
retrorsine, which blocks the recipient hepatocyte cell cycle, in conjunction with 
hepatectomy; but, undifferentiated ADMSCs did not (26, 27).  In our partial 
HIR+PVBL model, differentiation in vitro should be required to obtain 
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repopulation by ADMSCs. 
In summary, PVBL, which is applicable as PTE in the clinical setting, was efficient 
for transplanted hepatocytes to proliferate in combination with HIR.  Only 
partial HIR to small parts of liver should be enough to cure some hepatic 
metabolic disorders.  With this preparative method, SHs proliferated more 
quickly than PHs and could be a potential source for HT.  ADMSCs should be 
transplanted after differentiation in vitro, and the therapeutic effects on disorders 
should be evaluated. 
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Fig. 1.  Partial hepatic irradiation (HIR) and portal vein branch ligation (PVBL) 
 
Fig. 2.  DPPIV histochemistry showed massive hepatic repopulation of donor 
hepatocytes (red) only in the irradiated lobes 16 weeks after HT with preparative 
HIR and a growth stimulus (PVBL) (A).  Repopulated donor hepatocytes 
expressed connexin 32 (B) and PCK-1 (C), and stored glycogen (D). 
 
Fig. 3.  Serum bilirubin concentrations after hepatocyte transplantation.  Only 
the rats in the HIR+PVBL group (diamonds, n=8) showed a continuously 
significant decline in serum bilirubin concentrations compared with the other two 
groups (circles; the non-HT group p=0.002, and triangles; the PVBL group p=0.002, 
Mann-Whitney’s U test, n=6 each). 
 
Fig. 4. PCNA staining after partial HIR+PVBL.  While many PCNA-positive 
hepatocytes were seen in the non-irradiated lobe 48 hours after operation, positive 
cells were rare in the irradiated lobe. 
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Fig. 5.  Serum HGF after PVBL+partial HIR (ELISA).  After PVBL+partial HIR, 
the serum HGF levels did not show significant fluctuations over time (ANOVA, 
n=3-5 each). 
 
Fig. 6.  Recipient livers after 8 weeks of transplantation.  Massive hepatic 
repopulation was acquired after SH transplantation in the irradiated lobes (A, 
DPPIV histochemistry) and repopulated SHs showed storage of glycogen (B, PAS 
stain).  Although ADMSCs seemed to be engrafted in the recipient liver, 
repopulation was not acquired (C and D, DPPIV histochemistry).  E shows that 
the ratio of repopulated areas after 8 weeks of transplantation in the irradiated 
lobes.  The transplanted SHs proliferated more rapidly than PHs (p<0.038, 
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